Adaptive Biotechnologies Corporation (ADPT)

Healthcare · Diagnostics Research · NASDAQ

Adaptive Biotechnologies Corporation (ADPT) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $4.48B and a free-cash-flow yield of -1.1%. Over the most recent reported fiscal year, revenue grew 54.8%.

Market cap	$4.48B
Trailing P/E	—
FCF yield	-1.1%
Revenue growth (YoY)	+54.8%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Diagnostics Research

Explore live ADPT data on Nama Insights →